SCHEMBL13902870

SCHEMBL13902870

NCCC#Cc1cc2c(c(C(=O)N[C@@H](CO)Cc3c[nH]c4ccccc34)c1)OCCCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 3/20 0.40
ITGB2 P05107 5/20 0.37
ICAM1 P05362 5/20 0.37
ITGAL P20701 5/20 0.37
HTR1A P08908 1/20 0.37
SLC6A4 P31645 1/20 0.37
USP2 O75604 1/20 0.36
MAPK1 P28482 1/20 0.36
SNCA P37840 2/20 0.36
HDAC3 O15379 4/20 0.36
HDAC1 Q13547 4/20 0.36
HDAC2 Q92769 4/20 0.36
HDAC4 P56524 3/20 0.36
HDAC7 Q8WUI4 3/20 0.36
HDAC10 Q969S8 3/20 0.36
HDAC11 Q96DB2 3/20 0.36
HDAC8 Q9BY41 3/20 0.36
HDAC6 Q9UBN7 3/20 0.36
HDAC9 Q9UKV0 3/20 0.36
HDAC5 Q9UQL6 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13962345 0.96 ECE1 (0.39) ECE1ITGB2ICAM1ITGALHTR1A
SCHEMBL13960316 0.96 ECE1 (0.39) ECE1ITGB2ICAM1ITGALHTR1A
SCHEMBL13902875 0.94 ECE1 (0.39) ECE1ITGB2ICAM1ITGALHTR1A
SCHEMBL13960314 0.94 ECE1 (0.39) ECE1ITGB2ICAM1ITGALHTR1A
SCHEMBL13902864 0.93 ECE1 (0.40) ECE1ITGB2ICAM1ITGALHTR1A
SCHEMBL13902872 0.92 ECE1 (0.38) ECE1ITGB2ICAM1ITGALHTR1A
SCHEMBL13902874 0.91 ECE1 (0.37) ECE1ITGB2ICAM1ITGALHTR1A
SCHEMBL3945780 0.91 ECE1 (0.37) ECE1ITGB2ICAM1ITGALHTR1A
SCHEMBL13902880 0.90 ECE1 (0.36) ECE1HTR1ASLC6A4USP2MAPK1
SCHEMBL13962172 0.89 ALDH1A1 (0.38) ECE1HTR1ASLC6A4USP2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090075987-A1 ALKYLACETYLENE SUBSTITUTED ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2009-03-19 US disclosed
WO-2009013333-A1 ALKYLACETYLENE SUBSTITUTED ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-01-29 WO disclosed
EP-2019102-A1 Alkylacetylene substituted Acyltryptophanols Bayer Schering Pharma AG (DE) 2009-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090075987-A1 ALKYLACETYLENE SUBSTITUTED ACYLTRYPTOPHANOLS FSHR, GNRHR, CYP19A1 ECE1 1561/4885ITGB2 2779/4885ICAM1 3647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.